What is GI Logic?
GI Logic specializes in developing advanced solutions for gastrointestinal health, most notably its wearable biosensor, AbStats. This device offers non-invasive monitoring of digestive health, functioning akin to a fitness tracker but for internal well-being. It aims to support patients in weight management and recovery post-surgery. The company primarily serves hospitals and gastroenterologists, seeking to elevate patient care within the gastroenterology sector through technological advancements. GI Logic is positioned at the vanguard of creating novel vital signs for GI tracking, transforming healthcare delivery.
How much funding has GI Logic raised?
GI Logic has raised a total of $3.3M across 1 funding round:
Private Equity
$3.3M
Private Equity (2016): $3.3M, investors not publicly disclosed
What's next for GI Logic?
The substantial enterprise-level backing suggests GI Logic is poised for significant scaling and market penetration. This strategic investment will likely fuel further research and development of their AbStats wearable, potentially expanding its capabilities and applications. The company may also focus on broadening its client base within the healthcare system, forging new partnerships with medical institutions and potentially exploring direct-to-consumer avenues. Continued innovation in GI monitoring technology is expected, solidifying GI Logic's role as a leader in health-tech.
See full GI Logic company page
